ArticleMolecular therapy : the journal of the American Society of Gene Therapy2022

Engineered bispecific antibodies targeting the interleukin-6 and -8 receptors potently inhibit cancer cell migration and tumor metastasis.

Huilin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.